enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Kenvue - Wikipedia

   en.wikipedia.org/wiki/Kenvue

   Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson , [ 3 ] Kenvue is the proprietor of well-known brands such as Aveeno , [ 4 ] Band-Aid , [ 5 ] Benadryl , Combantrin , Zyrtec , [ 6 ] Johnson's , [ 7 ] Listerine , [ 8 ] Mylanta , Neutrogena , [ 4 ] Trosyd , Calpol , Tylenol , [ 8 ...

3. McNeil Consumer Healthcare - Wikipedia

   en.wikipedia.org/wiki/McNeil_Consumer_Healthcare

   The name, pronounced ken-view, comes from the English word "ken," which is primarily used on Scotland and means knowledge, and "vue," which references sight. Kenvue, which will become a standalone company in 2023, will include in its portfolio brands such as Band-Aid, Aveeno, Listerine, Tylenol and Neutrogena. [citation needed]

4. Neutrogena - Wikipedia

   en.wikipedia.org/wiki/Neutrogena

   Neutrogena "Norwegian Formula" hand cream. Neutrogena Corporation, [1] trading as Neutrogena, is an American company that produces cosmetics, skin care and hair care, is owned by parent company Kenvue and is headquartered in Skillman, New Jersey. [2]

5. Listerine-maker Kenvue beats estimates on strong essential ...

   www.aol.com/news/listerine-maker-kenvue-beats...

   Kenvue's skin health business, which sells brands such as Neutrogena and Clean & Clear, was the worst performer, recording a nearly 4% decline in sales to $1.10 billion, compared with LSEG ...

6. Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit ...

   www.aol.com/news/tylenol-maker-kenvue-beats...

   (Reuters) -Kenvue will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall Street estimates for first ...

7. Johnson & Johnson - Wikipedia

   en.wikipedia.org/wiki/Johnson_&_Johnson

   In September 2022, Johnson & Johnson chose Kenvue as the new name for its Consumer Health business. Kenvue went public through an IPO in May 2023, with Johnson & Johnson maintaining a controlling stake of around 91 percent. [82] On July 24, 2023, Johnson & Johnson launched an exchange offer to split-off Kenvue. [83]